Archived Content

Information released online from June 2012 to September 2017.Note: Content in this archive site is NOT UPDATED, and external links may not function. External links to other Internet sites should not be construed as an endorsement of the views contained therein.

USAID Administrator Green Announces PMI Launch and Expansion in West and Central Africa

For Immediate Release

Thursday, September 21, 2017

Office of Press Relations

Telephone: +1.202.712.4320 | Email: press@usaid.gov

Today, United States Agency for International Development (USAID) Administrator Mark Green announced that the U.S. President's Malaria Initiative (PMI), led by USAID and implemented together with the U.S. Centers for Disease Control and Prevention (CDC), will launch new country programs in Cameroon, Cote d'Ivoire, Niger, and Sierra Leone, and expand its existing program in Burkina Faso.

With the addition of five new focus countries in West and Central Africa, PMI will have programs in 24 countries in sub-Saharan Africa, where malaria remains a significant public health problem. This is in addition to PMI's two bilateral programs and targeted support in the Greater Mekong Subregion in Asia, aimed at combating antimalarial drug resistance.PMI's country expansion will benefit almost 90 million additional people at risk of malaria. The U.S. Government will now contribute to ensuring the availability of effective malaria prevention and control interventions to approximately 332 million people at risk across the west-to-central African corridor from Senegal to Cameroon. While launching and expanding PMI, the U.S. Government remains committed to partnering with existing PMI focus countries to accelerate progress in malaria control and continue the momentum towards elimination.

Together with partner countries, under national malaria control program leadership, and in collaboration with malaria stakeholders, PMI scales up a comprehensive, integrated package of life-saving interventions in communities. This includes both prevention (insecticide-treated mosquito nets, intermittent preventive treatment of pregnant women, seasonal malaria chemoprevention, and indoor residual spraying) and treatment interventions (malaria diagnosis and treatment with artemisinin-based combination therapies). PMI support builds overall country capacity and strengthens health systems while improving malaria prevention and treatment services. PMI support includes strengthening supply chain logistics, malaria case surveillance, and monitoring and evaluation of impact.

More than 480 million people at risk of malaria have benefitted from PMI programs. In Fiscal Year 2016, PMI protected over 16 million people by spraying homes, distributed more than 42 million long-lasting insecticide-treated bed nets, and provided 57 million treatments of life-saving drugs and 63 million rapid diagnostic tests.